INTELLIGENT BIO SOLUTIONS IN (INBS) Stock Price & Overview
NASDAQ:INBS • US36151G7097
The current stock price of INBS is 4.16 USD. Today INBS is up by 1.46%. In the past month the price decreased by -28.28%. In the past year, price decreased by -80.68%.
INBS Key Statistics
- Market Cap
- 6.656M
- P/E
- N/A
- Fwd P/E
- 11.65
- EPS (TTM)
- -15.13
- Dividend Yield
- N/A
INBS Stock Performance
INBS Stock Chart
INBS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to INBS. When comparing the yearly performance of all stocks, INBS is a bad performer in the overall market: 95.62% of all stocks are doing better.
INBS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to INBS. While INBS seems to be doing ok healthwise, there are quite some concerns on its profitability.
INBS Earnings
INBS Forecast & Estimates
For the next year, analysts expect an EPS growth of 128% and a revenue growth 126.26% for INBS
INBS Groups
Sector & Classification
INBS Financial Highlights
Over the last trailing twelve months INBS reported a non-GAAP Earnings per Share(EPS) of -15.13. The EPS increased by 57.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -63.98% | ||
| ROE | -101.81% | ||
| Debt/Equity | 0 |
INBS Ownership
INBS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.11 | 192.101B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.28 | 172.54B | ||
| SYK | STRYKER CORP | 22.89 | 137.252B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.06 | 103.813B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.38 | 49.778B | ||
| IDXX | IDEXX LABORATORIES INC | 39.72 | 47.68B | ||
| BDX | BECTON DICKINSON AND CO | 11.85 | 46.663B | ||
| RMD | RESMED INC | 19.52 | 35.999B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.04 | 33.147B | ||
| DXCM | DEXCOM INC | 26.28 | 26.09B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.73 | 17.941B | ||
| HOLX | HOLOGIC INC | 15.36 | 16.864B | ||
| PODD | INSULET CORP | 36.49 | 16.772B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INBS
Company Profile
Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. The company is headquartered in New York City, New York and currently employs 16 full-time employees. The company went IPO on 2020-12-23. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Company Info
IPO: 2020-12-23
INTELLIGENT BIO SOLUTIONS IN
135 W 41St St,, Floor 5
New York City NEW YORK US
Employees: 54
Phone: 16467905756
INTELLIGENT BIO SOLUTIONS IN / INBS FAQ
Can you describe the business of INTELLIGENT BIO SOLUTIONS IN?
Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. The company is headquartered in New York City, New York and currently employs 16 full-time employees. The company went IPO on 2020-12-23. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
What is the stock price of INTELLIGENT BIO SOLUTIONS IN today?
The current stock price of INBS is 4.16 USD. The price increased by 1.46% in the last trading session.
Does INTELLIGENT BIO SOLUTIONS IN pay dividends?
INBS does not pay a dividend.
What is the ChartMill rating of INTELLIGENT BIO SOLUTIONS IN stock?
INBS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is INTELLIGENT BIO SOLUTIONS IN (INBS) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INBS.
What is the Short Interest ratio of INTELLIGENT BIO SOLUTIONS IN (INBS) stock?
The outstanding short interest for INTELLIGENT BIO SOLUTIONS IN (INBS) is 2.77% of its float.